MLPKF yields 7.71% · JNJ yields 2.13%● Live data
📍 MLPKF pulled ahead of the other in Year 1
Combined, MLPKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MLPKF + JNJ for your $10,000?
MLP SE, together with its subsidiaries, provides financial brokerage and consulting services to private, corporate, and institutional clients in Germany. The company's Financial Consulting segment offers consulting services for academics and other clients related to insurance, investments, occupational pension provision schemes, and loans and mortgages, as well as the brokering of contracts in financial services. Its Banking segment provides banking services, such as accounts, credit cards, loans, mortgages, and wealth management services. This segment also offers securities custody, commission, investment consulting, and insurance and investment brokerage services. The company's FERI segment provides wealth and investment consulting, as well as investment management and research services for institutional investors and high net-worth families and foundations. Its DOMCURA segment operates as an underwriting agency that designs, develops, and implements coverage concepts in the field of private and corporate non-life insurance products, as well as provides brokerage services. The company's Industrial Broker segment brokering of insurance policies for industrial and commercial clients, as well as consulting services and insurances. Its Holding and Others segment develops real estate properties. MLP SE was founded in 1971 and is headquartered in Wiesloch, Germany.
Full MLPKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.